Jeffrey Hsu

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Epithelial Mesenchymal Transition

Cell Cycle Arrest

Top Venues

Arthritis & rheumatology (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Deepraj Ghosh, Jeffrey Hsu, Kylen Soriano, Carolina Mejia Peña, Amy H Lee, Don S Dizon, Michelle R Dawson
Spatial Heterogeneity in Cytoskeletal Mechanics Response to TGF-β1 and Hypoxia Mediates Partial Epithelial-to-Meshenchymal Transition in Epithelial Ovarian Cancer Cells. Cancers 15 (12) (2023)
Deepraj Ghosh, Jeffrey Hsu, Kylen Soriano, Carolina Mejia Peña, Amy H Lee, Don S Dizon, Michelle R Dawson
Spatial Heterogeneity in Cytoskeletal Mechanics Response to TGF-β1 and Hypoxia Mediates Partial Epithelial-to-Meshenchymal Transition in Epithelial Ovarian Cancer Cells. Cancers 15 (12) (2023)
Jeffrey Hsu, Chin-Hsiu Liu, James C Wei
Suggested Considerations for the Treatment of Rheumatic Diseases in Adult Patients With COVID-19: Comment on the Article by Mikuls et al. Arthritis & rheumatology (Hoboken, N.J.) 73 (12) (2021)
Gabriel K Griffin, Jingyi Wu, Arvin Iracheta-Vellve, James C Patti, Jeffrey Hsu, Thomas Davis, Deborah Dele-Oni, Peter P Du, Aya G Halawi, Jeffrey J Ishizuka, Sarah Y Kim, Susan Klaeger, Nelson H Knudsen, Brian C Miller, Tung H Nguyen, Kira E Olander, Malvina Papanastasiou, Suzanna Rachimi, Emily J Robitschek, Emily M Schneider, Mitchell D Yeary, Margaret D Zimmer, Jacob D Jaffe, Steven A Carr, John G Doench, W Nicholas Haining, Kathleen B Yates, Robert T Manguso, Bradley E Bernstein
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity. Nature 595 (7866) (2021)